Alps Medical Breakthroughs ETF (SBIO) closed at $56.03 on October 29, 2026, down 0.1% from the previous close, on volume of 11,459 shares (30-day average 39,863).
Data as of October 29, 2026.
No headlines found.
No press releases found.
No news found.
The Fund seeks investment results that correspond (before fees and expenses) generally to the performance of its underlying index, the S-Network Medical Breakthroughs Index (ticker symbol PMBI) (the "Underlying Index"). The ALPS Medical Breakthroughs ETF invests in the public equity markets of the United States and in the stocks of companies operating in the biotechnology sectors. The fund invests in stocks of mid cap and small cap companies with a market capitalization of no less than $200 million and no more than $5 billion. It seeks to replicate the performance of the S-Network Medical Breakthroughs Index, by investing in the stocks of companies as per their weightings in the index.
Alps Medical Breakthroughs ETF trades on the ARCA stock market under the symbol SBIO.
As of October 29, 2026, SBIO stock price declined to $56.03 with 11,459 million shares trading.
SBIO has a beta of 1.08, meaning it tends to be more sensitive to market movements. SBIO has a correlation of 0.16 to the broad based SPY ETF.
SBIO has a market cap of $189.11 million. This is considered a Micro Cap stock.
In the last 3 years, SBIO traded as high as $70.85 and as low as $22.33.
SBIO has outperformed the market in the last year with a price return of +25.5% while the SPY ETF gained +13.1%. However, in the short term, SBIO had mixed performance relative to the market. It has underperformed in the last 3 months, returning -11.8% vs +4.1% return in SPY. But in the last 2 weeks, SBIO shares have fared better than the market returning +9.4% compared to SPY 0.0%.
SBIO support price is $54.74 and resistance is $57.44 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SBIO shares will trade within this expected range on the day.
